BACKGROUND:Placental malaria is a major cause of adverse birth outcomes. However, data are limited on the relationships between longitudinal measures of parasitemia during pregnancy and placental malaria. METHODS: Data came from 637 women enrolled in a randomized controlled trial of intermittent preventive treatment of malaria in pregnancy (IPTp) from Uganda. Plasmodium falciparum parasitemia was assessed using microscopy and ultrasensitive quantitative PCR at intervals of 28 days from 12 to 20 weeks gestation through delivery. Multivariate analysis was used to measure associations between characteristics of parasitemia during pregnancy and the risk of placental malaria based on histopathology. RESULTS:Overall risk of placental malaria was 44.6%. None of the 34 women without parasitemia detected during pregnancy had evidence of placental malaria. Increasing proportion of interval assessments with parasitemia and higher parasite densities were independently associated with an increased risk of placental malaria. Higher gravidity and more effective IPTp were associated with a decreased risk of placental malaria. Women with parasitemia only detected before the third trimester still had an increased risk of placental malaria. CONCLUSIONS: The frequency, density, and timing of parasitemia are all important risk factors for placental malaria. Interventions should target the prevention of all levels of parasitemia throughout pregnancy.
RCT Entities:
BACKGROUND:Placental malaria is a major cause of adverse birth outcomes. However, data are limited on the relationships between longitudinal measures of parasitemia during pregnancy and placental malaria. METHODS: Data came from 637 women enrolled in a randomized controlled trial of intermittent preventive treatment of malaria in pregnancy (IPTp) from Uganda. Plasmodium falciparum parasitemia was assessed using microscopy and ultrasensitive quantitative PCR at intervals of 28 days from 12 to 20 weeks gestation through delivery. Multivariate analysis was used to measure associations between characteristics of parasitemia during pregnancy and the risk of placental malaria based on histopathology. RESULTS: Overall risk of placental malaria was 44.6%. None of the 34 women without parasitemia detected during pregnancy had evidence of placental malaria. Increasing proportion of interval assessments with parasitemia and higher parasite densities were independently associated with an increased risk of placental malaria. Higher gravidity and more effective IPTp were associated with a decreased risk of placental malaria. Women with parasitemia only detected before the third trimester still had an increased risk of placental malaria. CONCLUSIONS: The frequency, density, and timing of parasitemia are all important risk factors for placental malaria. Interventions should target the prevention of all levels of parasitemia throughout pregnancy.
Authors: Meghna Desai; Julie Gutman; Anne L'lanziva; Kephas Otieno; Elizabeth Juma; Simon Kariuki; Peter Ouma; Vincent Were; Kayla Laserson; Abraham Katana; John Williamson; Feiko O ter Kuile Journal: Lancet Date: 2015-09-28 Impact factor: 79.321
Authors: Steve M Taylor; Mwayiwawo Madanitsa; Kyaw-Lay Thwai; Carole Khairallah; Linda Kalilani-Phiri; Anna M van Eijk; Victor Mwapasa; Feiko O Ter Kuile; Steven R Meshnick Journal: J Infect Dis Date: 2017-08-01 Impact factor: 5.226
Authors: Patrick G T Walker; Feiko O ter Kuile; Tini Garske; Clara Menendez; Azra C Ghani Journal: Lancet Glob Health Date: 2014-07-23 Impact factor: 26.763
Authors: Heidi Hopkins; Iveth J González; Spencer D Polley; Patrick Angutoko; John Ategeka; Caroline Asiimwe; Bosco Agaba; Daniel J Kyabayinze; Colin J Sutherland; Mark D Perkins; David Bell Journal: J Infect Dis Date: 2013-04-30 Impact factor: 5.226
Authors: Mwayiwawo Madanitsa; Linda Kalilani; Victor Mwapasa; Anna M van Eijk; Carole Khairallah; Doreen Ali; Cheryl Pace; James Smedley; Kyaw-Lay Thwai; Brandt Levitt; Duolao Wang; Arthur Kang'ombe; Brian Faragher; Steve M Taylor; Steve Meshnick; Feiko O Ter Kuile Journal: PLoS Med Date: 2016-09-13 Impact factor: 11.069
Authors: James Kapisi; Abel Kakuru; Prasanna Jagannathan; Mary K Muhindo; Paul Natureeba; Patricia Awori; Miriam Nakalembe; Richard Ssekitoleko; Peter Olwoch; John Ategeka; Patience Nayebare; Tamara D Clark; Gabrielle Rizzuto; Atis Muehlenbachs; Diane V Havlir; Moses R Kamya; Grant Dorsey; Stephanie L Gaw Journal: Malar J Date: 2017-10-05 Impact factor: 2.979
Authors: Emma Hughes; Erika Wallender; Richard Kajubi; Prasanna Jagannathan; Teddy Ochieng; Abel Kakuru; Moses R Kamya; Tamara D Clark; Philip J Rosenthal; Grant Dorsey; Francesca Aweeka; Radojka M Savic Journal: Clin Infect Dis Date: 2022-08-31 Impact factor: 20.999
Authors: Erin E Tran; Morgan L Cheeks; Abel Kakuru; Mary K Muhindo; Paul Natureeba; Miriam Nakalembe; John Ategeka; Patience Nayebare; Moses Kamya; Diane Havlir; Margaret E Feeney; Grant Dorsey; Stephanie L Gaw Journal: Malar J Date: 2020-06-24 Impact factor: 2.979
Authors: Makoto Saito; Rashid Mansoor; Kalynn Kennon; Anupkumar R Anvikar; Elizabeth A Ashley; Daniel Chandramohan; Lauren M Cohee; Umberto D'Alessandro; Blaise Genton; Mary Ellen Gilder; Elizabeth Juma; Linda Kalilani-Phiri; Irene Kuepfer; Miriam K Laufer; Khin Maung Lwin; Steven R Meshnick; Dominic Mosha; Atis Muehlenbachs; Victor Mwapasa; Norah Mwebaza; Michael Nambozi; Jean-Louis A Ndiaye; François Nosten; Myaing Nyunt; Bernhards Ogutu; Sunil Parikh; Moo Kho Paw; Aung Pyae Phyo; Mupawjay Pimanpanarak; Patrice Piola; Marcus J Rijken; Kanlaya Sriprawat; Harry K Tagbor; Joel Tarning; Halidou Tinto; Innocent Valéa; Neena Valecha; Nicholas J White; Jacher Wiladphaingern; Kasia Stepniewska; Rose McGready; Philippe J Guérin Journal: BMC Med Date: 2020-06-02 Impact factor: 8.775
Authors: Natalie M Quanquin; Lauren G Barres; Saba R Aliyari; Nathan T Day; Hoda Gerami; Susan J Fisher; Abel Kakuru; Moses R Kamya; Diane V Havlir; Margaret Feeney; Grant Dorsey; Genhong Cheng; Stephanie L Gaw Journal: Malar J Date: 2020-08-05 Impact factor: 2.979